tradmap

FLNA Earnings FILANA THERAPEUTICS, INC.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$2 -$1 $1 $0 2013 2013 2013 2013 2014 2015 2022 2023 2024 2025
EPS
Net income (annual)
-$97M -$49M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-123% -61% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q1 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25
EPS
Net income (quarterly)
-$44M -$10M $25M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income
Return on equity (quarterly)
-50% -9% 32% 0% Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
ROE

Reported EPS history

1–23 of 23
FY 20252025-12-31-1.882026-03-1210-K
Q3 20252025-09-30-1.622025-11-1210-Q
Q2 20252025-06-30-1.402025-08-1410-Q
Q1 20252025-03-31-0.482025-05-0810-Q
FY 20252024-12-31-1.462026-03-1210-K
Q3 20252024-09-30-0.882025-11-1210-Q
Q2 20252024-06-30-0.282025-08-1410-Q
Q1 20252024-03-31-0.432025-05-0810-Q
FY 20252023-12-31-2.322026-03-1210-K
Q3 20242023-09-30-1.822024-11-0710-Q
Q2 20242023-06-30-1.212024-08-0810-Q
Q1 20242023-03-31-0.582024-05-1010-Q
FY 20242022-12-31-1.902025-03-0310-K
Q2 20232022-06-30-0.922023-08-0310-Q
Q1 20232022-03-31-0.442023-05-0110-Q
FY 20152015-12-31-0.312016-03-0310-K
FY 20152014-12-31-0.272016-03-0310-K
FY 20152013-12-310.702016-03-0310-K
FY 20152013-09-30-0.022016-03-0310-K
FY 20152013-06-30-0.012016-03-0310-K
FY 20152013-03-31-0.012016-03-0310-K
FY 20142012-12-31-0.082015-02-1810-K
FY 20132011-12-31-0.062014-02-0510-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.